Detalhe da pesquisa
1.
Generation of genetically engineered mice for lung cancer with mutant EGFR.
Biochem Biophys Res Commun
; 632: 85-91, 2022 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206598
2.
A nonbiodegradable scaffold-free cell sheet of genome-engineered mesenchymal stem cells inhibits development of acute kidney injury.
Kidney Int
; 99(1): 117-133, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853632
3.
miR-34c-5p and CaMKII are involved in aldosterone-induced fibrosis in kidney collecting duct cells.
Am J Physiol Renal Physiol
; 314(3): F329-F342, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070573
4.
Yeast-derived particulate beta-glucan induced angiogenesis via regulating PI3K/Src and ERK1/2 signaling pathway.
Int J Biol Macromol
; 269(Pt 2): 131884, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38685541
5.
HDAC5-mediated exosomal Maspin and miR-151a-3p as biomarkers for enhancing radiation treatment sensitivity in hepatocellular carcinoma.
Biomater Res
; 27(1): 134, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102691
6.
Immortalization of primary marmoset skin fibroblasts by CRISPR-Cas9-mediated gene targeting.
Anim Cells Syst (Seoul)
; 26(6): 266-274, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36605591
7.
The reversible fourth-generation EGFR tyrosine kinase inhibitor OBX02-011 overcomes C797S-mediated resistance in lung cancer.
Cancer Res
; 2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700239
8.
Correction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer.
Cancer Res
; : OF1, 2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006687
9.
Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer.
Cancer Res
; : OF1, 2022 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018295